CIK 0001651308 · Large accelerated filer
BeOne Medicines Ltd.
Sign in to watch- Ticker
- BEIGF
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981209416
- Phone
- 41-616851900
- Business address
- C/O BEONE MEDICINES I GMBH, AESCHENGRABEN 27, 21ST FLOOR, BASEL, Switzerland, 4051
- Former names
- BeiGene, Ltd.
Securities
- ONC American Depositary Shares Nasdaq
- BEIGF Common stock OTC
- SC 13G Stake Amended Statement of Ownership
- 8-K Event Material agreement · Unregistered share sale · Shareholder rights changed · Executive or director change · Bylaws or fiscal year change
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Insider Changes in Ownership
- SC 13D Stake Beneficial Ownership Report
- S-8 Other Securities Offered to Employees in Benefit Plans
- CT ORDER Other Confidential Order
- 424B4 Offering Prospectus
- CERTNAS Other Certification by the Nasdaq Stock Market
- EFFECT Other Notice of Effectiveness
- EFFECT Other Notice of Effectiveness
- S-1MEF Other S-1MEF
Page 62 of 64 · 1,278 filings